Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Curcumin in Critically Ill Patients With Sepsis [NA]

View source ↗

Summary

A clinical trial is evaluating curcumin in critically ill patients with sepsis, and the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Hospital Civil de Guadalajara | Conditions: Sepsis | NA | Status: NOT_YET_RECRUITING